FOXP3 and cancer: Aside from this observation, our present findings largely confirm and expand upon those of Muto et al as they resoundingly demonstrate that without TRAF6, FOXP3 protein levels and the gene expression pattern typical of Tregs are poorly maintained to the detriment of immune control at baseline and in distinct disease models (i.e., colitis and cancer).